logo

Canadian News

Share

Canadian shares look headed for a mixed start on Wednesday as investors, looking for trade related news and the progress in Brexit talks, are very likely to make cautious moves.

biotechnology-oct16.jpg The following are the healthcare stocks that hit a new 52-week high on Tuesday.

The euro strengthened against its major counterparts in early European deals on Wednesday. The euro rose to 0.8677 against the pound and 1.1027 against the franc, from its early lows of 0.8625 and 1.1002, respectively. The European currency appreciated to a 5-day high of 1.1060 against the greenback...

Abacus Health Products, Inc., a manufacturer of CBD-based topical pain-relief treatments, said it will enter the U.S. convenience store market segment through a distribution agreement with E&S International Enterprises, Inc. or ESI. Canada-based Abacus Health manufactures and sells over-the-counter...

pharmadown-oct15.jpg The following are some of the healthcare stocks that posted the biggest percentage decline on Tuesday.

pharmaup-oct15.jpg The following are some of today's top gainers in the healthcare sector.

After a steady start and a subsequent smart uptick, the Canadian stock market started paring gains gradually and eventually ended Tuesday's session just marginally up, as traders largely stayed wary of holding positions at higher levels.

The Canadian stock market opened on a steady note and was up in positive territory with modest gains around noon, riding on some upbeat results from big-name U.S. companies and on easing concerns about Brexit.

imf-101519.jpg Global economy is set to expand at the slowest pace in a decade this year amid weak manufacturing momentum, and rising trade and geopolitical tensions, the International Monetary Fund said Tuesday. The global lender cut the growth forecast for this year to 3 percent from 3.3 percent projected in April, in its latest World Economic Outlook.

Canada existing home sales for September have been released at 9:00 am ET Tuesday. After the data, the loonie changed little against its major counterparts. The loonie was trading at 81.90 against the yen, 0.8939 against the aussie, 1.4564 against the euro and 1.3229 against the greenback around 9:04 am ET.

Canada existing home sales for September are due at 9:00 am ET Tuesday. Ahead of the data, the loonie traded mixed against its major counterparts. While the loonie rose against the euro and the aussie, it held steady against the greenback and the yen. The loonie was worth 81.90 against the yen, 0.8936...

Canadian shares are likely to edge higher Tuesday morning, tracking gains in European markets where the mood was slightly positive amid optimism about a Brexit deal.

dtock-oct15.jpg The following are the healthcare stocks that hit a new 52-week low on Monday.

melinta1-oct15.jpg Melinta Therapeutics Inc. (MLNT), which has gained 59 percent over the last two months, awaits a regulatory catalyst next week.

pharma-052417_15oct19.jpg Today's Daily Dose brings you news about the delay in FDA decision of Flexion's supplemental New Drug Application for ZILRETTA; launch of NOURIANZ, an adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing "off" episodes, in the U.S.; Reata Pharma's Friedreich's Ataxia trial data; and upcoming clinical trial catalyst of Relmada Therapeutics.

Follow RTT
>